Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Unraveling the Life Cycle of Metastatic Cells from Invasion to Outgrowth.

Project description

Decoding colorectal cancer metastasis

Colorectal cancer is the second leading cause of cancer-related deaths worldwide, with common metastatic spread to the liver and lungs. Effective therapies to prevent this progression are lacking, partly due to limited understanding of how cancer cells disseminate and establish distant tumours. The ERC-funded META-CYCLE project will study the metastatic cascade through a systems biology approach. Researchers will perform multi-omics analysis to identify specific drivers of invasion seeding and outgrowth. They will also investigate the role of the liver microenvironment and endothelial cells in promoting metastasis. Project findings will provide a comprehensive picture of metastatic colorectal cancer, paving the way for novel therapeutic strategies to limit disease progression.

Objective

Colorectal cancer (CRC) is the second leading cause of cancer-related mortality worldwide, accounting for
nearly 10% of cancer-related deaths. The majority of CRC-related deaths result from metastatic
dissemination, with the liver and lung being the most frequent distant sites of metastasis. Effective therapies
to prevent metastatic CRC progression are lacking. This gap stems from our limited understanding of the
cancer-intrinsic and tumor microenvironmental factors that drive advancement through each intermediate
step of the metastatic cascade.
Here, we will use systems approaches to unravel the life cycle of metastatic cells, focusing on cancer cell
plasticity and interactions with host tissues. First, we will use in vivo CRISPR screening to identify drivers
of invasion, dissemination, seeding, and outgrowth. This approach will be complemented by single-cell
multi-omics analyses to uncover the regulatory networks governing these processes. Next, we will explore
the dynamics of the liver pre-metastatic niche using single-cell RNA sequencing, proximity labeling, and
immunofluorescence to dissect its metastasis-promoting cellular networks and gradual reversal after primary
tumor ablation. Finally, we will identify host factors that regulate metastatic extravasation and vessel co-
option by functionally investigating the role of liver endothelial cells throughout metastatic progression.
This will be achieved through a combination of in vivo interaction screening, in vitro models, and
comparison to spatial transcriptomic datasets from patient samples.
By integrating these complementary approaches, our study aims to provide a comprehensive understanding
of the key drivers and modulators of metastatic CRC. These insights could pave the way for the development
of novel therapeutic strategies aimed at preventing or limiting metastatic disease progression in CRC
patients.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2025-COG

See all projects funded under this call

Host institution

EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH
Net EU contribution
€ 2 535 325,00
Address
Raemistrasse 101
8092 Zuerich
Switzerland
Region
Schweiz/Suisse/Svizzera Zürich Zürich
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 2 538 825,00

Beneficiaries (1)